[Answered] Subjects in an experiment who do not receive the experimental treatment are part of the a. ...

This topic contains a solution. Click here to go to the answer

Author Question: Subjects in an experiment who do not receive the experimental treatment are part of the a. ... (Read 49 times)

maychende

Hero Member
Posts: 556

on: Aug 13, 2018

Subjects in an experiment who do not receive the experimental treatment are part of the

a. control group
b. placebo group
c. treatment group
d. experimental group

Question 2

____________________ refers to the ability to take findings from an experiment and apply them to the real world.

Fill in the blank(s) with correct word

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

Laurenleakan

Sr. Member
Posts: 309

Reply #1 on: Aug 13, 2018

Answer to Question 1

a

Answer to Question 2

Generalizability

maychende

Member
Posts: 556

Reply 2 on: Aug 13, 2018

Great answer, keep it coming

softEldritch

Member
Posts: 334

Reply 3 on: Yesterday

Wow, this really help

« previous next »

Did you know?

During pregnancy, a woman is more likely to experience bleeding gums and nosebleeds caused by hormonal changes that increase blood flow to the mouth and nose.

Did you know?

Giardia is one of the most common intestinal parasites worldwide, and infects up to 20% of the world population, mostly in poorer countries with inadequate sanitation. Infections are most common in children, though chronic Giardia is more common in adults.

Did you know?

Of the estimated 2 million heroin users in the United States, 600,000–800,000 are considered hardcore addicts. Heroin addiction is considered to be one of the hardest addictions to recover from.

Did you know?

Children with strabismus (crossed eyes) can be treated. They are not able to outgrow this condition on their own, but with help, it can be more easily corrected at a younger age. It is important for infants to have eye examinations as early as possible in their development and then another at age 2 years.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.